J
JiMED
Health Tech & Medtech · Suita-Shi, Japan · Founded 2020
a medical device venture from Osaka University that is responsible for the social implementation of the implantable BCI (Brain Computer Interface) MoreLess
GiMED Inc. is a pioneering medical venture founded by Shirata Shinnobu of Osaka University, specializing in the development and social implementation of wireless embedded Brain-Computer Interface (BCI) technology. The company focuses on leveraging advanced AI and buried devices to accurately read brain activity, enabling users to control devices simply through thought. GiMED's primary market includes patients with Amyotrophic Lateral Sclerosis (ALS), aiming to significantly improve their communication abilities and overall quality of life (QOL). The business model revolves around the commercialization of its BCI technology, targeting healthcare providers, research institutions, and directly serving patients. Revenue is generated through the sale of BCI devices, software solutions, and ongoing support services. By integrating cutting-edge AI with medical technology, GiMED is positioned at the forefront of neurotechnology innovation.
Keywords: BCI, ALS, AI, brain activity, communication, quality of life, neurotechnology, healthcare, medical devices, innovation.
Company overview
JiMED company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Suita-Shi, Japan
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 76.7
Valuation & funding
JiMED funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2026 | $2.5M | $10M | Keio Innovation Initiative | ↗ |
| SERIES A✓Equity / VC | Feb 2025 | $2.3M | $9.2M | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Dec 2024 | $1.6M | $6.3M | NEDO · Green Core · Keio Innovation Initiative | — |
| EARLY VC✓Equity / VC | Feb 2023 | $1.2M | $4.6M | Osaka University Venture Capital | ↗ |
| SEED✓Equity / VC | Mar 2021 | $1.5M | $6.2M | Mizuho Capital · Osaka University Venture Capital | — |
| SEED✓Equity / VC | Nov 2020 | Undisclosed | — | ||
| SPINOUT✓Other financing | Mar 2020 | Osaka University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 6 |
Growth signals
JiMED website traffic
Latest recorded traffic for JiMED is 3K monthly website visits, up 100% over the last three months.
Comparisons
JiMED compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
JiMED's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on JiMED's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where JiMED has talent and traffic
team presence
In the news
Latest news about JiMED
Recent press, funding announcements, and product moves mentioning JiMED — open to read from the original sources.
Market sentiment
What the market is saying about JiMED
An AI-synthesized read of the highest-engagement posts about JiMED on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See JiMED’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.